Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Current marketed FLOLAN (epoprostenol sodium)[1] Epoprostenol (Flolan)[1] Epoprostenol 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Flolan[1] Epoprostenol (Flolan)[1] Epoprostenol 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
3FLOLAN injection with currently marketed diluent[1] Epoprostenol (Flolan)[1] Epoprostenol 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4FLOLAN injection with reformulated diluent[1] Epoprostenol (Flolan)[1] Epoprostenol 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
5FLOLAN TM and Glycine Diluent[2] Epoprostenol (Flolan),
Glycine (Sterile Diluent for Flolan Injection)		[2] Glycine ,
Epoprostenol 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6Flolan®[1] Epoprostenol (Flolan)[1] Epoprostenol 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
7FLOLAN™ and Glycine Diluent[2] Epoprostenol (Flolan),
Glycine (Sterile Diluent for Flolan Injection)		[2] Glycine ,
Epoprostenol 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬